Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ultrasound Market To Bounce Back In 2021; Pandemic Will Accelerate Adoption Of New Tech

Executive Summary

Omdia expects revenue for ultrasound systems to contract by 8.4% in 2020, but to pick up again in 2021.

You may also be interested in...



Philips Steps Up Ultrasound Game With Lumify 4.0

The new version of Philips' Lumify gives clinicians access to pulse wave Doppler ultrasound technology, providing real-time blood flow information.

Handheld Ultrasound Developer Exo Raised $220M In Series C

As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date. 

Analyst Insight: Unmasking The Impact Of COVID-19 On The Ultrasound Market

The ultrasound market took a big hit from the COVID-19 pandemic, but the crisis also spurred product and technological development, according to a report from Informa's Omdia Ultrasound Intelligence Service.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT142658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel